Astrazeneca
Found 3 recent publications

The new CEO of AstraZeneca Israel
The international pharmaceutical company is appointing Maria Miller as CEO of the Israeli branch, after Ohad Goldberg, who held the position for the last eight years, was appointed CEO of the operations in South Korea. Burger Ranch is launching a new campaign created using artificial intelligence, with an investment of 3 million shekels.

A massive $400 billion merger may shake up the pharmaceutical market
Reports of preliminary merger talks between British pharmaceutical giant AstraZeneca and its American competitor Bristol Myers Squibb have sparked significant market interest this week. This is a move that could lead to one of the largest deals in the industry's history, creating a combined company worth approximately $400 billion. Although a senior source denied the existence of the talks and...

Potential AstraZeneca and BMS Merger: A $400 Billion Pharmaceutical Giant
Reports indicate that pharmaceutical giants AstraZeneca and Bristol-Myers Squibb (BMS) are in talks regarding a potential merger. If successful, the deal could create a combined entity with a market capitalization of nearly $400 billion, marking one of the largest transactions in industry history.